학술논문
Emerging Toxicities of Antibody-Drug Conjugates for Breast Cancer: Clinical Prioritization of Adverse Events from the FDA Adverse Event Reporting System
Document Type
Article
Author
Source
In: Targeted Oncology . (Targeted Oncology, May 2024, 19(3):435-445)
Subject
Language
English
ISSN
1776260X
17762596
17762596